Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
AbbVie
ABBV
|
+$384M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Intuit
INTU
|
+$350M |
| 4 |
ICU Medical
ICUI
|
+$295M |
| 5 |
Netflix
NFLX
|
+$287M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
+$673M |
| 2 |
American Tower
AMT
|
+$538M |
| 3 |
Apple
AAPL
|
+$456M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$436M |
| 5 |
Meta Platforms (Facebook)
META
|
+$384M |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Healthcare | 17.84% |
| 3 | Financials | 12.82% |
| 4 | Industrials | 11.63% |
| 5 | Consumer Discretionary | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Glaukos
GKOS
$5.27B
| $119M | 0.08% |
2,115,992
-1,021,881
| -33% | -$57.4M |
|
302
Guidewire Software
GWRE
$22B
| $119M | 0.08% |
1,477,610
-58,948
| -4% | -$4.73M |
|
303
Public Service Enterprise Group
PEG
$40B
| $118M | 0.08% |
2,274,605
+823,057
| +57% | +$42.8M |
|
304
M&T Bank
MTB
$31.1B
| $118M | 0.08% |
824,149
+96,631
| +13% | +$13.8M |
|
305
Regions Financial
RF
$24.1B
| $118M | 0.08% |
8,802,151
-364,641
| -4% | -$4.88M |
|
306
Xcel Energy
XEL
$42.4B
| $117M | 0.07% |
2,379,347
+40,233
| +2% | +$1.98M |
|
|
MDSO
307
DELISTED
Medidata Solutions, Inc.
MDSO
| $117M | 0.07% |
1,733,839
-28,184
| -2% | -$1.9M |
|
|
BHVN
308
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $116M | 0.07% |
3,143,758
-193,158
| -6% | -$7.14M |
|
309
PagSeguro Digital
PAGS
$2.78B
| $116M | 0.07% |
6,195,247
+1,547,303
| +33% | +$29M |
|
310
McCormick & Company Non-Voting
MKC
$18.8B
| $116M | 0.07% |
1,662,596
+969,848
| +140% | +$67.5M |
|
311
Micron Technology
MU
$147B
| $115M | 0.07% |
3,638,202
-5,862,052
| -62% | -$186M |
|
312
Travelers Companies
TRV
$61.8B
| $115M | 0.07% |
963,119
+61,318
| +7% | +$7.34M |
|
|
DPLO
313
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $115M | 0.07% |
8,551,019
+2,658,973
| +45% | +$35.8M |
|
314
Comerica
CMA
$8.83B
| $114M | 0.07% |
1,652,444
+96,234
| +6% | +$6.61M |
|
315
Protolabs
PRLB
$1.2B
| $113M | 0.07% |
1,004,938
-60,118
| -6% | -$6.78M |
|
316
Rogers Corp
ROG
$1.42B
| $113M | 0.07% |
1,138,641
+106,145
| +10% | +$10.5M |
|
|
DISCK
317
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $112M | 0.07% |
4,864,934
+2,047,323
| +73% | +$47.3M |
|
|
NTUS
318
DELISTED
Natus Medical Inc
NTUS
| $111M | 0.07% |
3,269,186
+157,425
| +5% | +$5.36M |
|
319
DuPont de Nemours
DD
$32.6B
| $111M | 0.07% |
1,025,377
-315,824
| -24% | -$34.1M |
|
320
ResMed
RMD
$40.9B
| $111M | 0.07% |
970,591
+707,275
| +269% | +$80.5M |
|
321
Prosperity Bancshares
PB
$6.46B
| $110M | 0.07% |
1,769,122
-276,493
| -14% | -$17.2M |
|
322
Teck Resources
TECK
$17.2B
| $110M | 0.07% |
5,096,413
-2,188,826
| -30% | -$47.1M |
|
|
CNH
323
CNH Industrial
CNH
$14.4B
| $109M | 0.07% |
13,992,538
-1,821,542
| -12% | -$14.2M |
|
324
Avnet
AVT
$4.45B
| $109M | 0.07% |
3,021,382
+204,722
| +7% | +$7.39M |
|
325
Advanced Micro Devices
AMD
$246B
| $109M | 0.07% |
5,900,643
+5,600,283
| +1,865% | +$103M |
|